Revolutionizing Maternal Care: Cedars-Sinai's AI Innovations to Mitigate Pregnancy Health Risks

Cedars-Sinai researchers are leveraging artificial intelligence (AI) to mitigate critical health risks related to pregnancy and childbirth, while enhancing screening for specific gynecological cancers. Leading this transformative effort is Dr. Melissa Wong, a maternal-fetal medicine expert and director of Informatics and AI Strategies within the Department of Obstetrics and Gynecology. Notably, recent studies focused on major threats like preeclampsia and postpartum hemorrhage. The findings indicate that AI can effectively identify at-risk patients for preeclampsia, significantly increasing appropriate treatment while eliminating racial disparities. Additionally, an innovative algorithm predicts severe postpartum bleeding by evaluating comprehensive labor data. Future applications may optimize Pap smear analyses and manage gestational diabetes and hypertension effectively, ultimately streamlining care and advancing patient outcomes. This approach emphasizes practical AI implementations that democratize healthcare access across diverse populations.